Financials

Discussions Technicals Seasonals

302550 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

REMED Co., Ltd. engages in the development and manufacture of medical devices related to electronic medication. The firm focuses on brain rehabilitation business that utilizes Transcranial Magnetic Stimulation for the purpose of non-invasive treatment and rehabilitation of brain diseases. It also specializes in chronic pain treatment business using Neuro Magnetic Stimulation and an aesthetic business using Core Muscle Strengthen Magnetic Stimulation to strengthen muscles. The company was founded on July 31, 2003 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

302550 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company